epilepsiaEpilepsy and paroxysmal conditionsЭпилепсия и пароксизмальные состояния2077-83332311-4088IRBIS LLCepilepsia-103Research ArticleCLINICAL LECTURESКЛИНИЧЕСКИЕ ЛЕКЦИИПЕРАМПАНЕЛ: ФАРМАКОКИНЕТИКА И ЛЕКАРСТВЕННЫЕ ВЗАИМОДЕЙСТВИЯПатсалосФ. Н.
Филип Н. Патсалос - профессор, руководитель отдела клинической фармакологии и терапии Университетского колледжа
Лондонский Институт неврологииUnited Kingdom20140606201665Special issue1618Copyright © Патсалос Ф.Н., 20162016Патсалос Ф.Н.Патсалос Ф.Н.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.epilepsia.su/jour/article/view/103
.
ReferencesFuseau E., Templeton D., Hussein Z. Population Pharmacokinetics and Pharmacodynamics of Perampanel in Patients with Refractory Partial Seizures. Epilepsy Currents. 2011; 11 (1): Abs 1.264.Fuseau E., Templeton D., Hussein Z. Population Pharmacokinetics and Pharmacodynamics of Perampanel in Patients with Refractory Partial Seizures. Epilepsy Currents. 2011; 11 (1): Abs 1.264.Hussein Z., Critchley D., Ferry J., Laurenza A. Population Pharmacokinetics of Perampanel, a Selective, Non-competitive AMPA Receptor Antagonist, in Patients with Refractory Partial Onset Seizures Participating in a Randomized, Double-blind, Placebo-controlled Phase III Study. Epilepsia. 2011; 52 (6): 248-9.Hussein Z., Critchley D., Ferry J., Laurenza A. Population Pharmacokinetics of Perampanel, a Selective, Non-competitive AMPA Receptor Antagonist, in Patients with Refractory Partial Onset Seizures Participating in a Randomized, Double-blind, Placebo-controlled Phase III Study. Epilepsia. 2011; 52 (6): 248-9.Laurenza A., Ferry J., Hussein Z. Population Pharmacokinetics and Pharmacodynamics of Perampanel: APooled Analysis From Three Phase III Trials. Epilepsy Currents. 2012; 12 (1): 216-7.Laurenza A., Ferry J., Hussein Z. Population Pharmacokinetics and Pharmacodynamics of Perampanel: APooled Analysis From Three Phase III Trials. Epilepsy Currents. 2012; 12 (1): 216-7.Patsalos P.N. Drug Interactions With the Newer Antiepileptic Drugs (AEDs) – Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs. Clinical Pharmacokinetics. 2013a; 52: 927-966.Patsalos P.N. Drug Interactions With the Newer Antiepileptic Drugs (AEDs) – Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs. Clinical Pharmacokinetics. 2013a; 52: 927-966.Patsalos P.N. Drug Interactions with the Newer antiepileptic drugs (AEDs) – Part 2: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs and Drugs Used to Treat Non-epilepsy Disorders. Clinical Pharmacokinetics. 2013b; 52: 1045-1061.Patsalos P.N. Drug Interactions with the Newer antiepileptic drugs (AEDs) – Part 2: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs and Drugs Used to Treat Non-epilepsy Disorders. Clinical Pharmacokinetics. 2013b; 52: 1045-1061.Инструкция по медицинскому применению прапарата Файкомпа РУ ЛП 002200 от 23.08.2013.Инструкция по медицинскому применению прапарата Файкомпа РУ ЛП 002200 от 23.08.2013.
The authors declare that there are no conflicts of interest present.